Morgan Stanley Maintains Equal-Weight on Contineum Therapeutics, Raises Price Target to $16

Morgan Stanley analyst Jeffrey Hung maintains Contineum Therapeutics (NASDAQ:CTNM) with a Equal-Weight and raises the price target from $14 to $16.